Prevention of Bortezomib-Induced Peripheral Neuropathy in Newly Multiple Myeloma Patients Using Nervonic Acid, Curcuma Rizoma, and L-Arginine Compound: A Pilot Study

Prevention of Bortezomib-Induced Peripheral Neuropathy in Newly Multiple Myeloma Patients Using Nervonic Acid, Curcuma Rizoma, and L-Arginine Compound: A Pilot Study

Introduction: This is a phase II pilot study to evaluate the efficacy of a nutraceutical compound composed of nervonic acid, curcuma rizoma, and l-Arginine to prevent the onset of bortezomib-induced peripheral neuropathy (BIPN) in 16 newly diagnosed multiple myeloma (MM) patients treated with bortez...

Full description

Bibliographic Details
Main Authors: Marta Maschio MD, Andrea Maialetti PsyD, Francesco Marchesi MD, Svitlana Gumenyuk MD, Francesco Pisani MD, Elena Papa MD, Edvina Galiè MD, Tatiana Koudriavtseva MD, Giuliana Graziano NFPT, Diana Giannarelli MD, Andrea Mengarelli MD
Format: Article
Language:English
Published: SAGE Publishing 2022-07-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354221114142

Internet

https://doi.org/10.1177/15347354221114142

Similar Items